Close Menu

Precision Oncology Tools & Technology

The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics.

PanCAN has invested $25 million in the study, which will screen blood samples from new-onset diabetes patients for biomarkers associated with pancreatic cancer.

The new partners seek to close the information loop by including providers, payors, and patients in biomarker-guided cancer therapy decisions.

Researchers said that the score further may identify patients whose treatment resistance may be overcome with combination strategies targeting certain cells.

Based on results from a pilot study, Dutch lawmakers are advancing a proposal to make WGS a standard test for advanced cancer patients.

The technology vendor and the PBM will offer a bundled platform to help guide cancer patients to the most appropriate treatments.